nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—DDC—renal system—rectum cancer	0.0813	0.0814	CbGeAlD
Amantadine—SLC22A2—renal system—rectum cancer	0.067	0.067	CbGeAlD
Amantadine—DDC—female reproductive system—rectum cancer	0.0651	0.0652	CbGeAlD
Amantadine—GRIN2A—vagina—rectum cancer	0.063	0.0631	CbGeAlD
Amantadine—SIGMAR1—seminal vesicle—rectum cancer	0.0542	0.0543	CbGeAlD
Amantadine—MAOB—seminal vesicle—rectum cancer	0.0519	0.052	CbGeAlD
Amantadine—SLC22A1—renal system—rectum cancer	0.0473	0.0473	CbGeAlD
Amantadine—SIGMAR1—smooth muscle tissue—rectum cancer	0.0454	0.0454	CbGeAlD
Amantadine—SIGMAR1—urethra—rectum cancer	0.0429	0.043	CbGeAlD
Amantadine—MAOB—renal system—rectum cancer	0.0418	0.0419	CbGeAlD
Amantadine—MAOB—urethra—rectum cancer	0.0411	0.0411	CbGeAlD
Amantadine—SIGMAR1—mammalian vulva—rectum cancer	0.0409	0.0409	CbGeAlD
Amantadine—MAOB—mammalian vulva—rectum cancer	0.0391	0.0392	CbGeAlD
Amantadine—DDC—lymph node—rectum cancer	0.0381	0.0381	CbGeAlD
Amantadine—SLC22A1—vagina—rectum cancer	0.0343	0.0343	CbGeAlD
Amantadine—MAOB—female reproductive system—rectum cancer	0.0335	0.0335	CbGeAlD
Amantadine—SIGMAR1—vagina—rectum cancer	0.0316	0.0317	CbGeAlD
Amantadine—MAOB—vagina—rectum cancer	0.0303	0.0303	CbGeAlD
Amantadine—SIGMAR1—lymph node—rectum cancer	0.0205	0.0205	CbGeAlD
Amantadine—MAOB—lymph node—rectum cancer	0.0196	0.0196	CbGeAlD
Amantadine—ABCB1—seminal vesicle—rectum cancer	0.0189	0.019	CbGeAlD
Amantadine—ABCB1—epithelium—rectum cancer	0.0164	0.0165	CbGeAlD
Amantadine—ABCB1—renal system—rectum cancer	0.0153	0.0153	CbGeAlD
Amantadine—ABCB1—urethra—rectum cancer	0.015	0.015	CbGeAlD
Amantadine—ABCB1—mammalian vulva—rectum cancer	0.0143	0.0143	CbGeAlD
Amantadine—ABCB1—female reproductive system—rectum cancer	0.0122	0.0122	CbGeAlD
Amantadine—ABCB1—vagina—rectum cancer	0.011	0.0111	CbGeAlD
Amantadine—ABCB1—lymph node—rectum cancer	0.00715	0.00715	CbGeAlD
Amantadine—SLC22A2—Amine compound SLC transporters—SLC14A2—rectum cancer	9.94e-05	0.0974	CbGpPWpGaD
Amantadine—SLC22A1—Amine compound SLC transporters—SLC14A2—rectum cancer	9.26e-05	0.0908	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	3.89e-05	0.0381	CbGpPWpGaD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	3.62e-05	0.0355	CbGpPWpGaD
Amantadine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—rectum cancer	3.59e-05	0.0352	CbGpPWpGaD
Amantadine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—rectum cancer	3.34e-05	0.0327	CbGpPWpGaD
Amantadine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—rectum cancer	2.74e-05	0.0269	CbGpPWpGaD
Amantadine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—rectum cancer	2.56e-05	0.0251	CbGpPWpGaD
Amantadine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—rectum cancer	2.39e-05	0.0234	CbGpPWpGaD
Amantadine—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—rectum cancer	2.38e-05	0.0233	CbGpPWpGaD
Amantadine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—rectum cancer	2.33e-05	0.0229	CbGpPWpGaD
Amantadine—GRIN2C—Post NMDA receptor activation events—HRAS—rectum cancer	2.11e-05	0.0207	CbGpPWpGaD
Amantadine—GRIN2D—Post NMDA receptor activation events—HRAS—rectum cancer	1.96e-05	0.0192	CbGpPWpGaD
Amantadine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—rectum cancer	1.96e-05	0.0192	CbGpPWpGaD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—rectum cancer	1.94e-05	0.019	CbGpPWpGaD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—rectum cancer	1.81e-05	0.0177	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	1.77e-05	0.0173	CbGpPWpGaD
Amantadine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—rectum cancer	1.71e-05	0.0167	CbGpPWpGaD
Amantadine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—rectum cancer	1.66e-05	0.0163	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	1.65e-05	0.0161	CbGpPWpGaD
Amantadine—GRIN2A—Post NMDA receptor activation events—HRAS—rectum cancer	1.61e-05	0.0158	CbGpPWpGaD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—rectum cancer	1.48e-05	0.0145	CbGpPWpGaD
Amantadine—GRIN1—Post NMDA receptor activation events—HRAS—rectum cancer	1.4e-05	0.0138	CbGpPWpGaD
Amantadine—GRIN2B—Post NMDA receptor activation events—HRAS—rectum cancer	1.37e-05	0.0134	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TYMS—rectum cancer	1.33e-05	0.013	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—rectum cancer	1.29e-05	0.0127	CbGpPWpGaD
Amantadine—GRIN1—EPHB-mediated forward signaling—HRAS—rectum cancer	1.29e-05	0.0127	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—rectum cancer	1.26e-05	0.0124	CbGpPWpGaD
Amantadine—GRIN2B—EPHB-mediated forward signaling—HRAS—rectum cancer	1.26e-05	0.0124	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—ITGA2—rectum cancer	1.2e-05	0.0118	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TP53—rectum cancer	1.2e-05	0.0118	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—ITGA2—rectum cancer	1.17e-05	0.0115	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TP53—rectum cancer	1.12e-05	0.0109	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—rectum cancer	9.17e-06	0.00899	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	8.98e-06	0.0088	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—ITGA2—rectum cancer	8.59e-06	0.00842	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—ITGA2—rectum cancer	8.37e-06	0.0082	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	8.37e-06	0.0082	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TP53—rectum cancer	8e-06	0.00784	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TP53—rectum cancer	7.8e-06	0.00764	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	7.27e-06	0.00713	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	6.76e-06	0.00662	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—HRAS—rectum cancer	6.66e-06	0.00653	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—HRAS—rectum cancer	6.49e-06	0.00636	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—rectum cancer	5.8e-06	0.00569	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	5.55e-06	0.00544	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—HRAS—rectum cancer	5.47e-06	0.00536	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TYMS—rectum cancer	5.24e-06	0.00514	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—HRAS—rectum cancer	5.08e-06	0.00498	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	4.9e-06	0.00481	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	4.84e-06	0.00475	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—HRAS—rectum cancer	4.73e-06	0.00464	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—rectum cancer	4.72e-06	0.00463	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—HRAS—rectum cancer	4.61e-06	0.00452	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—rectum cancer	4.41e-06	0.00432	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—HRAS—rectum cancer	4.19e-06	0.0041	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—HRAS—rectum cancer	4.17e-06	0.00409	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—HRAS—rectum cancer	3.89e-06	0.00382	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—HRAS—rectum cancer	3.64e-06	0.00357	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—HRAS—rectum cancer	3.55e-06	0.00348	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—NRAS—rectum cancer	3.38e-06	0.00331	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	3.38e-06	0.00331	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—NRAS—rectum cancer	3.3e-06	0.00323	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—HRAS—rectum cancer	3.2e-06	0.00313	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—KRAS—rectum cancer	2.91e-06	0.00285	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—KRAS—rectum cancer	2.84e-06	0.00278	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—HRAS—rectum cancer	2.79e-06	0.00273	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—HRAS—rectum cancer	2.72e-06	0.00266	CbGpPWpGaD
Amantadine—DDC—Metabolism—TYMS—rectum cancer	2.58e-06	0.00253	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—HRAS—rectum cancer	2.47e-06	0.00242	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—NRAS—rectum cancer	2.41e-06	0.00237	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—HRAS—rectum cancer	2.41e-06	0.00236	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—NRAS—rectum cancer	2.35e-06	0.00231	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TYMS—rectum cancer	2.17e-06	0.00213	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—KRAS—rectum cancer	2.08e-06	0.00204	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—KRAS—rectum cancer	2.02e-06	0.00198	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—HRAS—rectum cancer	1.89e-06	0.00185	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—HRAS—rectum cancer	1.77e-06	0.00173	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—rectum cancer	1.76e-06	0.00173	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—rectum cancer	1.74e-06	0.0017	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—rectum cancer	1.72e-06	0.00169	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—rectum cancer	1.45e-06	0.00142	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—rectum cancer	1.35e-06	0.00132	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	1.26e-06	0.00124	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TYMS—rectum cancer	1.15e-06	0.00113	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	1.12e-06	0.0011	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TYMS—rectum cancer	1.07e-06	0.00105	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TYMS—rectum cancer	6.29e-07	0.000616	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NRAS—rectum cancer	6.23e-07	0.000611	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—KRAS—rectum cancer	5.37e-07	0.000526	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—rectum cancer	4.56e-07	0.000447	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRAS—rectum cancer	3.68e-07	0.000361	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KRAS—rectum cancer	3.17e-07	0.000311	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—rectum cancer	2.82e-07	0.000276	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—rectum cancer	2.69e-07	0.000264	CbGpPWpGaD
